Scinai Immunotherapeutics (SCNI) Other Working Capital Changes (2021 - 2026)
Scinai Immunotherapeutics (SCNI) posted Other Working Capital Changes of -$78000.0 for Q1 2026, down 124.3% sequentially from $321000.0 in Q2 2025, and up 7.14% YoY from -$72800.0 in Q1 2025.
Scinai Immunotherapeutics (SCNI) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Other Working Capital Changes for 8 years, with the latest figure at -$78000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 7.14% year-over-year to -$78000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $91000.0 (up 128.09% YoY) and the FY2025 annual result came in at $147000.0, up 146.82% from the prior year.
- Other Working Capital Changes declined to -$78000.0 in Q1 2026 per SCNI's latest filing, from $321000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $114000.0 in Q2 2024 and troughed at -$530000.0 in Q4 2024.
- A 5-year average of -$27750.0 and a median of $2000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes tumbled 2775.0% in 2024, then soared 379.13% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$166000.0 in 2022, then soared by 97.59% to -$4000.0 in 2023, then sank by 1600.0% to -$68000.0 in 2024, then jumped by 572.06% to $321000.0 in 2025, then tumbled by 124.3% to -$78000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$78000.0, $321000.0, and -$84000.0 for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106,000.00 |
| Mar 31, 2026 | 106,000.00 |
| Mar 31, 2026 | 106,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Dec 31, 2024 | -530,000.00 |
| Dec 31, 2024 | -530,000.00 |
| Dec 31, 2024 | -530,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Mar 31, 2024 | 75,000.00 |
| Mar 31, 2024 | 75,000.00 |